Third Rock Ventures II, L.P. - 03 Jun 2021 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Reporting relationship: 10%+ Owner
Issuer ticker: RVMD
Reported as of: 03 Jun 2021
Net transaction value: -$16,406,962
SEC form: 4
Accepted by SEC: 07 Jun 2021, 18:10:38 UTC
Prior SEC filing: 27 May 2021
Next SEC filing: 14 Jun 2021
Source filing: View source filing
Reporting owner signature: /s/ Kevin Gillis, Chief Operating Officer of TRV GP II, LLC, general partner of Third Rock Ventures GP II, L.P., general partner of Third Rock Ventures II, L.P.

Filing notes and source

Key filing fact

Third Rock Ventures II, L.P. filed Form 4 for Revolution Medicines, Inc. (RVMD) on 07 Jun 2021.

Key facts

This page summarizes Third Rock Ventures II, L.P.'s Form 4 filing for Revolution Medicines, Inc. (RVMD).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 07 Jun 2021, 18:10.

Change

Previous filing in this sequence was filed on 27 May 2021.
Current net transaction value: -$16,406,962.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RVMD transaction

Common Stock

Sale

Transaction value: $11,419,133
Shares: -378,117
Change %: -70%
Price: $30.20
Shares after: 164,996
Date: 03 Jun 2021
Ownership: Direct
Footnotes: F1, F2

RVMD transaction

Common Stock

Sale

Transaction value: $4,987,829
Shares: -164,996
Change %: -100%
Price: $30.23
Shares after: 0
Date: 04 Jun 2021
Ownership: Direct
Footnotes: F2, F3

RVMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,524,031
Date: 03 Jun 2021
Ownership: See footnote
Footnotes: F4

RVMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 0
Date: 03 Jun 2021
Ownership: See footnote
Footnotes: F4, F5

RVMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 116,334
Date: 03 Jun 2021
Ownership: Direct
Footnotes: F6

RVMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 12,925
Date: 03 Jun 2021
Ownership: See footnote
Footnotes: F7

RVMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 129,256
Date: 03 Jun 2021
Ownership: Direct
Footnotes: F8

RVMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 129,258
Date: 03 Jun 2021
Ownership: Direct
Footnotes: F9

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Third Rock Ventures II, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 9 footnotes

Footnote F1

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

Footnote F2

These shares are directly held by Third Rock Ventures II, L.P. ("TRV II"). The general partner of TRV II is Third Rock Ventures GP II, L.P. ("TRV GP II"). The general partner of TRV GP II is TRV GP II, LLC ("TRV GP II LLC"). The individual managers of TRV GP II LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.

Footnote F3

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.10 to $30.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3).

Footnote F4

These shares are directly held by Third Rock Ventures III, L.P. ("TRV III"). The general partner of TRV III is Third Rock Ventures GP III, L.P. ("TRV GP III"). The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual managers of TRV GP III LLC are Levin, Starr and Tepper. Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.

Footnote F5

Third Rock Ventures IV, L.P. ("TRV IV") directly holds 1,419,900 shares of Common Stock of the Issuer. The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of the reporting persons and TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.

Footnote F6

The shares are directly held by Levin.

Footnote F7

The shares are directly held by Levin Family 2014 Irrevocable Trust.

Footnote F8

The shares are directly held by Starr.

Footnote F9

The shares are directly held by Tepper.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .